Ferriprox® (deferiprone) Prescribing Information

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use FERRIPROX safely and effectively. See full prescribing information for FERRIPROX. FERRIPROX® (deferiprone) tablets, for oral use Initial U.S. Approval: 2011 WARNING: AGRANULOCYTOSIS/NEUTROPENIA See full prescribing information for complete boxed warning. INDICATIONS AND USAGE FERRIPROX® (deferiprone) is an iron chelator indicated for the treatment of…

Read more →

Ferriprox® (deferiprone) Prescribing Information and Medication Guide

Read this Medication Guide before you start taking FERRIPROX and each time you get a refill. There may be new information. This information does not take the place of talking to your healthcare provider about your medical condition or your treatment. What is the most important information I should know about FERRIPROX? FERRIPROX can cause serious side effects, including…

Read more →

Two-year observational study of deferiprone in superficial siderosis

Image-12

INTRODUCTION: Superficial siderosis is a rare, neurodegenerative disease caused by toxic accumulation of hemosiderin on the surface of the brain and the spinal cord, most commonly from chronic subarachnoid hemorrhage. AIMS: The aim of this study was to assess the clinical and radiological outcomes of superficial siderosis patients using deferiprone, a cell permeant iron chelator. Subjects obtained pre- and…

Read more →